Enova (ENVA) insider David Fisher exercises options and sells shares at $121.96 avg
Rhea-AI Filing Summary
David Fisher, Chief Executive Officer and a director of Enova International, Inc. (ENVA), reported transactions dated 09/04/2025. He acquired 20,000 shares through exercise of non-qualified stock options/SARs at an exercise price of $23.96 (reported as a non-derivative acquisition at $23.96) and concurrently sold 20,000 shares in multiple trades at a weighted-average sale price of $121.956 (actual trade prices ranged from $120.67 to $123.40). Following these transactions his beneficial ownership is reported as 348,223 shares. The option/SAR package vests in three equal installments (vesting completed by 02/12/2022) and the SAR has special exercise conditions tied to a change-in-control or qualifying offer. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 09/08/2025.
Positive
- Option exercise converted compensation into equity, increasing common shares owned before the sale by 20,000 shares.
- Realized proceeds from sale at a weighted-average price of $121.956, materially above the exercise price of $23.96.
- Substantial remaining ownership of 348,223 shares after the transactions, maintaining insider alignment with shareholders.
Negative
- Sale of 20,000 shares reduced the reporting person's holdings, lowering direct share count from 368,223 to 348,223.
- SAR exercise is contingent on a change-in-control or qualifying offer, meaning potential upside from the SAR is not currently accessible.
Insights
TL;DR: Insider exercised options at a low strike and sold an equal number of shares at ~5x the strike, reducing holdings modestly while realizing proceeds.
This Form 4 documents a routine executive option exercise paired with an open-market sale of the same number of shares. The exercise price of $23.96 is substantially below the reported weighted-average sale price of $121.956, indicating the exercise was economically accretive to the reporting person. The SAR component has termination and offer-triggered payout conditions which remain relevant to future compensation outcomes. No new employment, change-in-control, or unusual lockup terms are disclosed in the filing itself.
TL;DR: This is a standard option exercise plus market sale; it converts long-dated compensation into cash while keeping substantial equity ownership.
The options vested by 02/12/2022 and were exercised on 09/04/2025 for 20,000 shares at $23.96. The simultaneous sale of 20,000 shares at a weighted average near $121.96 realizes significant gain for the insider. Post-transaction ownership of 348,223 shares remains substantial, preserving alignment with shareholders. The filing provides full trade-price range disclosure upon request to regulators or shareholders.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Option (right to buy) with limited SAR | 20,000 | $0.00 | -- |
| Exercise | Common stock, par value $0.00001 per share | 20,000 | $23.96 | $479K |
| Sale | Common stock, par value $0.00001 per share | 20,000 | $121.956 | $2.44M |
Footnotes (1)
- This transaction was executed in multiple trades at prices ranging from $120.67 to $123.40. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer. The options vested in substantially equal one-third increments on each of the following dates: February 12, 2020, February 12, 2021, and February 12, 2022.
